Find a Tender
planned
Official procurement procedure
NHS England Continuous Glucose Monitoring and Insulin Pen Needles RFI
Medicinal products used in diabetes
Miscellaneous medical devices and products
UK
Published value
£215,000,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS England Continuous Glucose Monitoring and Insulin Pen Needles RFI". Published status: planned. Published value: £215,000,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | planned No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £215,000,000 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
6.1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statusplanned | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Sept 2024, 15:54 BST | Last source update6 Sept 2024, 15:54 BST | Recurring procurementNot published |
ClassificationMedicinal products used in diabetes, Miscellaneous medical devices and products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0498de | ||
What is being bought
NHS England is undertaking a Request for Information (RFI) exercise to explore the availability and supply of Continuous Glucose Monitoring (CGM) devices and Insulin Pen Needles. The aim of this Request for Information is to gather relevant information from suppliers in the market to better understand current offerings, innovations, and potential solutions that can support effective diabetes management in NHS services.<br/> <br/>This exercise is purely for information gathering purposes and does not constitute a formal procurement process. However, the information provided will assist NHS England in shaping potential future procurement strategies and ensuring that patients benefit from high-quality and cost-effective products.<br/> <br/>Key Areas of Interest:<br/>- The range of Continuous Glucose Monitoring devices available.<br/>- Features and benefits of CGM systems, including accuracy, ease of use, and connectivity with other diabetes management tools.<br/>- Insulin Pen Needles, including size, comfort, safety features, and availability of various gauges.<br/>- Innovations in the field of diabetes care, including new products or technologies.<br/>- Supplier capabilities, including delivery, support, and potential cost efficiencies.<br/> <br/>Suppliers with relevant products and services in these areas are encouraged to participate in the Request for Information process<br/> <br/>This PIN is for market engagement purposes only. Participation in this Request for Information does not constitute any offer or guarantee of future procurement, and it does not imply that a contract or tender will follow.<br/><br/>Providers wishing to provide information will need to respond with the information requested by the documentation and submit responses prior to the deadline stated in this notice. The RFI documentation including a questionnaire is available through the Atamis (Health Family) portal: https://health-family.force.com/s/Welcome. The reference is C305527 and the closing date for completed RFI responses is 17:00pm , on Wednesday 18th September 2024. To express interest and participate in this request for information exercise, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should<br/>Providers have any queries, or having problems using the portal, they should contact<br/>Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
What changed
From the official release history
- Published value updated to £215,000,000
6 Sept 2024, 15:54 BST - Status changed to planned
6 Sept 2024, 15:54 BST - Official notice release published
6 Sept 2024, 15:54 BST - Buyer information updated
6 Sept 2024, 15:54 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplannedPublished valueNot publishedAssessment of Drug Tariff medical devices used in the management of diabetes. Additional information: This PIN is for market engagement purposes only. Participation in this Request for Information does not constitute any offer or guarantee of future procurement, and it does not imply that a contract or tender will follow.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 Sept 2024, 15:54 BST
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-107961Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published